Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15956265 | 0.90 | KDM4E (0.38) | CYP3A4ALDH1A1RAB9AKDM4EABCB1 | |
| SCHEMBL20764434 | 0.88 | CYP3A4 (0.43) | CYP3A4ALDH1A1TSHRHSD17B10RAB9A | |
| SCHEMBL15956458 | 0.88 | TSHR (0.40) | ALDH1A1TSHRRAB9APOLBKDM4E | |
| SCHEMBL5108230 | 0.85 | CYP3A4 (0.54) | CYP3A4ALDH1A1TSHRHSD17B10RAB9A | |
| SCHEMBL8788034 | 0.84 | CYP3A4 (0.55) | CYP3A4ALDH1A1TSHRHSD17B10RAB9A | |
| SCHEMBL15956197 | 0.80 | ALDH1A1 (0.54) | CYP3A4ALDH1A1TSHRHSD17B10RAB9A | |
| SCHEMBL20764503 | 0.79 | EP300 (0.41) | CYP3A4ALDH1A1RAB9APOLBKDM4E | |
| SCHEMBL17368427 | 0.78 | CYP3A4 (0.50) | CYP3A4ALDH1A1TSHRHSD17B10RAB9A | |
| SCHEMBL8788296 | 0.78 | MAPT (0.49) | CYP3A4ALDH1A1RAB9AFLT3KDM4E | |
| SCHEMBL20764500 | 0.78 | ALDH1A1 (0.34) | CYP3A4ALDH1A1RAB9APOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2956437-B1 | ALBICIDIN DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS | UNIV BERLIN TECH (DE) | 2023-05-10 | — | — | EP | disclosed |
| US-10308595-B2 | Albicidin derivatives, their use and synthesis | Technische Universität Berlin (DE) | 2019-06-04 | — | — | US | disclosed |
| US-20150376120-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Technische Universität Berlin (DE) | 2015-12-31 | — | — | US | disclosed |
| US-20150376120-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Technische Universität Berlin (DE) | 2015-12-31 | — | — | US | disclosed |
| EP-2956437-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (FR) | 2015-12-23 | — | — | EP | disclosed |
| WO-2014125075-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Technische Universität Berlin (DE) | 2014-08-21 | — | — | WO | disclosed |
| WO-2014125075-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Technische Universität Berlin (DE) | 2014-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308595-B2 | Albicidin derivatives, their use and synthesis | MB, ALB, BCAT2 | CYP3A4 862/4885ALDH1A1 2409/4885TSHR 3877/4885 |
| US-20150376120-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | MB, ALB, BCAT2 | CYP3A4 862/4885ALDH1A1 2409/4885TSHR 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.